1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ
Appoints Biotech Executive Juan Sanchez, MD, to the Board of Directors
Reports Second Quarter 2025 Financial Results and Business Highlights
Shareholder votes
Other Events
Reports First Quarter 2025 Financial Results and Business Highlights
Reports 2024 Financial Results and Business Highlights
Announces Pricing of $13.5 Million Public Offering of Common Stock
Earnings Release
Q2
Q1
FY 2023
Q3
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload
SEC Staff Correspondence
S-1MEF